Maternal progestins as a possible cause of hypospadias

  • University of Bergen ROR

The New England Journal of Medicine, 300(2), 75-78

DOI 10.1056/NEJM197901113000206 PMID 364307

Abstract

HYPOSPADIAS is a common anomaly of the urogenital system. The prevalence rate reported by various birth-defect monitoring programs shows a rather wide variation, ranging from about five per 10,000 to about 30 per 10,000 births. During recent years increasing incidence has been reported from England and Wales1 and Norway.2 In the United States the Center for Disease Control, Atlanta, Georgia, has noted an annual increase in the reported incidence of 3 per cent per year from 1970 to 1975. Though relatively small, this increase was nevertheless statistically highly significant (P<0.0001).3 More frequent recognition and reporting of the condition may explain . . .

Topics

maternal progestins hypospadias risk, progesterone exposure pregnancy genital anomalies, hypospadias increasing incidence birth defects, progestin use pregnancy urogenital malformations, Aarskog hypospadias progestins, hormonal exposure fetal development male genitalia, birth defect monitoring hypospadias prevalence, exogenous progestins congenital anomalies, prenatal hormone exposure urogenital system anomalies, drug safety pregnancy progestational agents
PMID 364307 364307 DOI 10.1056/NEJM197901113000206 10.1056/NEJM197901113000206

Cite this article

Aarskog, D. (1979). Maternal progestins as a possible cause of hypospadias. *The New England journal of medicine*, *300*(2), 75-78. https://doi.org/10.1056/NEJM197901113000206

Related articles